Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
ANDRE BARRETO PEREIRA
🇧🇷
Brazil
Country
🇧🇷
Brazil
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant
Phase 4
Completed
Conditions
Renal Transplant Rejection
Immunosuppression
Interventions
Drug: Everolimus
Subscribe
First Posted Date
2010-11-11
Last Posted Date
2020-02-07
Lead Sponsor
Andre Barreto Pereira
Target Recruit Count
30
Registration Number
NCT01239472
Locations
🇧🇷
Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy